Who We Are

Who We Are

BioAsset Advisors is a team of dedicated and experienced individuals committed to helping our clients maximize the value of their assets and create shareholder value.

Each member of our firm has decades of pharmaceutical, consulting and financial advisory experience.  This combination of skills and expertise ensures that we formulate pragmatic, real-world solutions to meet our clients’ needs.

We welcome the opportunity to understand your firm’s challenges and develop specific solutions to address them.

Our Core Team

Jo K. Mohr – Jo has over 20 years of experience developing strategic growth plans for global OTC drug and Consumer Products companies and executing them through licensing, M&A, and strategic alliances, both in the US and internationally.

G. John Mohr – John is a multi-dimensional drug industry executive with expertise in managing emerging company issues.  His distinguished career includes management of multi-million dollar brands and building products from ‘bench-to-market.’ He has also executed or advised on numerous multi-million dollar transactions.

Michael G. Parker – Michael is an accomplished life sciences consultant with over 25 years of experience.  He has assisted a range companies, from the very largest to start-ups in successfully addressing the challenges of corporate, marketing, and R&D strategy and ensuring profitable growth, both organically and through transactions.